"programmed cell death" trang 3 - tải miễn phí từ tailieuXANH
Báo cáo khoa học: Plant oxylipins: role of jasmonic acid during programmed cell death, defence and leaf senescence

Báo cáo khoa học: Plant oxylipins: role of jasmonic acid during programmed cell death, defence and leaf senescence
16    43    0
Báo cáo khoa học: Programmed cell death Apoptosis and alternative deathstyles

Báo cáo khoa học: Programmed cell death Apoptosis and alternative deathstyles
13    46    0
Clinical outcome of pembrolizumab for various malignancies in single institute in Vietnam

Clinical outcome of pembrolizumab for various malignancies in single institute in Vietnam
4    42    0
Cysteine protease and cystatin expression and activity during soybean nodule development and senescence

Cysteine protease and cystatin expression and activity during soybean nodule development and senescence
13    52    0
Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients

Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients
9    62    0
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): Protocol for a multicenter phase II open label study

Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): Protocol for a multicenter phase II open label study
7    52    0
IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer

IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer
11    124    0
Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer

Heterogeneity of PD-L1 expression in primary tumors and paired lymph node metastases of triple negative breast cancer
9    76    0
Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: A meta-analysis

Prognostic value and clinicopathological characteristics of PD-L1 overexpression in non-Hodgkin lymphoma: A meta-analysis
10    63    0
Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab

Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab
6    49    0
The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma

The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma
12    61    0
‘DURVIT’: A phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: Safety, toxicity and effect on the primary tumour and lymph node microenvironment

‘DURVIT’: A phase-I trial of single low-dose durvalumab (Medi4736) IntraTumourally injected in cervical cancer: Safety, toxicity and effect on the primary tumour and lymph node microenvironment
8    64    0
Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells

Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells
13    50    0
Identification and phylogenetic analyses of VASt, an uncharacterized protein domain associated with lipid-binding domains in Eukaryotes

Identification and phylogenetic analyses of VASt, an uncharacterized protein domain associated with lipid-binding domains in Eukaryotes
12    52    0
Molecular dynamics of the immune checkpoint programmed cell death protein I, PD-1: Conformational changes of the BCloop upon binding of the ligand PD-L1 and the monoclonal antibody nivolumab

Molecular dynamics of the immune checkpoint programmed cell death protein I, PD-1: Conformational changes of the BCloop upon binding of the ligand PD-L1 and the monoclonal antibody nivolumab
12    57    0
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: The multicentre prospective Safe Stop trial

Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: The multicentre prospective Safe Stop trial
9    111    1
Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand1 staining: A retrospective study

Pembrolizumab with or without enzalutamide in selected populations of men with previously untreated metastatic castration-resistant prostate cancer harbouring programmed cell death ligand1 staining: A retrospective study
11    51    1
Genome-wide identification, evolution and expression analysis of the aspartic protease gene family during rapid growth of moso bamboo (Phyllostachys edulis) shoots

Genome-wide identification, evolution and expression analysis of the aspartic protease gene family during rapid growth of moso bamboo (Phyllostachys edulis) shoots
20    63    1
Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: A retrospective study

Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: A retrospective study
9    340    2
Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study

Safety, activity, and pharmacokinetics of camrelizumab in advanced Asian melanoma patients: A phase I study
10    133    1
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.